The Wall Street Journal has an article about using genomics to develop vaccines -- something that Novartis in particular has been developing. A vaccine for a certain form of meningitis, for instance, is showing promise in clinical trials and "Novartis plans to move [it] into a much-larger test involving thousands of children next year, says Rino Rappuoli, an Italian scientist who heads Novartis's vaccine research," according to the article.
But the Real Question Is, Would Jenny McCarthy Use Them?
Dec 17, 2007
What's Popular?